Cancer Letters
Volume 241, Issue 1 , Pages 49-58 , 8 September 2006

Secretome analysis of microarray data reveals extracellular events associated with proliferative potential in a cell line model of breast disease

Received 3 July 2005 ,Revised 29 September 2005 ,Accepted 7 October 2005.

References 

  1. Russo J, Russo IH. The pathway of neoplastic transformation of human breast epithelial cells. Radiat. Res. 2001;155:151–154
  2. Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, et al. Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression. Breast Cancer Res. 2004;6:R499–R513
  3. Ye Y, Qiu TH, Kavanaugh C, Green JE. Molecular mechanisms of breast cancer progression: lessons from mouse mammary cancer models and gene expression profiling. Breast Dis. 2004;19:69–82
  4. DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ, et al. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am. J. Pathol. 2004;164:1131–1139
  5. Li M, Lewis B, Capuco AV, Laucirica R, Furth PA. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis. Oncogene. 2000;19:1010–1019
  6. Skrzydlewska E, Sulkowska M, Koda M, Sulkowski S. Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J. Gastroenterol. 2005;11:1251–1266
  7. Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat. Rev. Cancer. 2005;5:29–41
  8. Schambony A, Kunz M, Gradl D. Cross-regulation of Wnt signaling and cell adhesion. Differentiation. 2004;72:307–318
  9. Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, et al. The case for early detection. Nat. Rev. Cancer. 2003;3:243–252
  10. Srivastava S, Gopal-Srivastava R. Biomarkers in cancer screening: a public health perspective. J. Nutr. 2002;132:2471S–2475S
  11. Arun B, Hortobagyi G. Progress in breast cancer chemoprevention. Endocr. Relat. Cancer. 2002;9:15–32
  12. Manson MM, Farmer PB, Gescher A, Steward WP. Innovative agents in cancer prevention. Recent Results Cancer Res. 2005;166:257–275
  13. Cersosimo RJ. Tamoxifen for prevention of breast cancer. Ann. Pharmacother. 2003;37:268–273
  14. Krishnamurthy S, Sneige N. Molecular and biologic markers of premalignant lesions of human breast. Adv. Anat. Pathol. 2002;9:185–197
  15. Fabian CJ, Kimler BF. Breast cancer chemoprevention: current challenges and a look toward the future. Clin. Breast Cancer. 2002;3:113–124
  16. Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond. Am. J. Surg. Pathol. 2003;27:836–841
  17. Dupont W, Page D. Risk factors for breast cancer in women with proliferative breast disease. N. Engl. J. Med. 1985;312:146–151
  18. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am. J. Pathol. 1996;148:313–319
  19. Miller FR. Xenograft models of premalignant breast disease. J. Mammary Gland Biol. Neoplasia. 2000;5:379–391
  20. Starcevic SL, Elferink C, Novak RF. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease. J. Natl Cancer Inst. 2001;93:776–782
  21. Starcevic SL, Diotte NM, Zukowski KL, Cameron MJ, Novak RF. Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD). Toxicol. Sci. 2003;75:74–81
  22. Clark GJ, Der CJ. Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res. Treat. 1995;35:133–144
  23. von Lintig FC, Dreilinger AD, Varki NM, Wallace AM, Casteel DE, Boss GR. Ras activation in human breast cancer. Breast Cancer Res. Treat. 2000;62:51–62
  24. Eckert LB, Repasky GA, Ulku AS, McFall A, Zhou H, Sartor CI, et al. Involvement of ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res. 2004;64:4585–4592
  25. Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, et al. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003;13:2265–2270
  26. Chen Y, Zhang Y, Yin Y, Gao G, Li S, Jiang Y, et al. SPD—a web-based secreted protein database. Nucleic Acids Res. 2004;33:D169–D173
  27. Grimmond SM, Miranda KC, Yuan Z, Davis MJ, Hume DA, Yagi K, et al. The mouse secretome: functional classification of the proteins secreted into the extracellular environment. Genome Res. 2003;13:1350–1359
  28. Dombkowski AA, Thibodeau BJ, Starcevic SL, Novak RF. Gene-specific dye bias in microarray reference designs. Fed. Eur. Biochem. Soc. Lett. 2004;560:120–124
  29. Heyer LJ, Kruglyak S, Yooseph S. Exploring expression data: identification and analysis of coexpressed genes. Genome Res. 1999;9:1106–1115
  30. Gene Ontology Consortium . The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2004;32:D258–D261
  31. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3
  32. Yuen T, Wurmbach E, Pfeffer RL, Ebersole BJ, Sealfon SC. Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res. 2002;30:e48
  33. Talvensaari-Mattila A, Paakko P, Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma. Br. J. Cancer. 2003;89:1270–1275
  34. Leppa S, Saarto T, Vehmanen L, Blomqvist C, Elomaa I. A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma. Clin. Cancer Res. 2004;10:1057–1063
  35. Feldmann KA, Pittelkow MR, Roche PC, Kumar R, Grande JP. Expression of an immediate early gene, IEX-1, in human tissues. Histochem. Cell Biol. 2001;115:489–497
  36. Wu MX. Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis. Apoptosis. 2003;8:11–18
  37. Kumar R, Lutz W, Frank E, Im H-J. Immediate early gene X-1 interacts with proteins that modulate apoptosis. Biochem. Biophys. Res. Commun. 2004;323:1293–1298
  38. Hu Y, Sun H, Drake J, Kittrell F, Abba MC, Deng L, et al. From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies. Cancer Res. 2004;64:7748–7755

PII: S0304-3835(05)00917-1

doi: 10.1016/j.canlet.2005.10.008

Cancer Letters
Volume 241, Issue 1 , Pages 49-58 , 8 September 2006

Article Tools

* Image Usage & Resolution